Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in Am J Geriatr Psychiatry

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    May 2018
  1. MUNRO CE, Donovan NJ, Amariglio RE, Papp KV, et al
    The Impact of Awareness of and Concern About Memory Performance on the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease Dementia.
    Am J Geriatr Psychiatry. 2018 May 3. pii: S1064-7481(18)30323.
    PubMed     Text format     Abstract available


    April 2018
  2. WOODWARD MR, Hafeez MU, Qi Q, Riaz A, et al
    Odorant Item Specific Olfactory Identification Deficit May Differentiate Alzheimer Disease From Aging.
    Am J Geriatr Psychiatry. 2018 Apr 19. pii: S1064-7481(18)30247.
    PubMed     Text format     Abstract available


    October 2017
  3. CONNORS MH, Ames D, Woodward M, Brodaty H, et al
    Psychosis and Clinical Outcomes in Alzheimer Disease: A Longitudinal Study.
    Am J Geriatr Psychiatry. 2017 Oct 20. pii: S1064-7481(17)30512.
    PubMed     Text format     Abstract available


    September 2017
  4. HUGHES TM, Lockhart SN, Smagula SF
    Blood Pressure's Role in Alzheimer Disease Pathology.
    Am J Geriatr Psychiatry. 2017 Sep 25. pii: S1064-7481(17)30468.
    PubMed     Text format    


    July 2017
  5. YOSHIDA K, Roberts R, Suzuki T, Lebowitz B, et al
    Lack of Early Improvement with Antipsychotics is a Marker for Subsequent Nonresponse in Behavioral and Psychological Symptoms of Dementia: Analysis of CATIE-AD Data.
    Am J Geriatr Psychiatry. 2017;25:708-716.
    PubMed     Text format     Abstract available


    June 2017
  6. ERSKINE D, Thomas AJ, Taylor JP, Savage MA, et al
    Neuronal Loss and Alpha-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies.
    Am J Geriatr Psychiatry. 2017;25:595-604.
    PubMed     Text format     Abstract available


    April 2017
  7. KENNEDY RE, Cutter GR, Wang G, Schneider LS, et al
    Challenging Assumptions About African American Participation in Alzheimer Disease Trials.
    Am J Geriatr Psychiatry. 2017 Apr 25. pii: S1064-7481(17)30306.
    PubMed     Text format     Abstract available


    March 2017
  8. GEDA YE, Krell-Roesch J, Sambuchi N, Michel BF, et al
    Neuropsychiatric Symptoms and Neuroimaging Biomarkers in Alzheimer Disease: "Which is the Cart and Which is the Horse?"
    Am J Geriatr Psychiatry. 2017 Mar 16. pii: S1064-7481(17)30256.
    PubMed     Text format    


  9. ROSENBERG PB
    New Insights Into Brain Mechanisms Underlying Neuropsychiatric Symptoms in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Mar 8. pii: S1064-7481(17)30243.
    PubMed     Text format    


    February 2017
  10. MATIAS-GUIU JA, Cabrera-Martin MN, Valles-Salgado M, Perez-Perez A, et al
    Neural Basis of Cognitive Assessment in Alzheimer Disease, Amnestic Mild Cognitive Impairment, and Subjective Memory Complaints.
    Am J Geriatr Psychiatry. 2017 Feb 3. pii: S1064-7481(17)30194.
    PubMed     Text format     Abstract available


    January 2017
  11. WEISSBERGER GH, Melrose RJ, Narvaez TA, Harwood D, et al
    18F-Fluorodeoxyglucose Positron Emission Tomography Cortical Metabolic Activity Associated with Distinct Agitation Behaviors in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Jan 31. pii: S1064-7481(17)30034.
    PubMed     Text format     Abstract available


  12. SMITH GS
    Molecular Imaging of the Nicotinic Cholinergic Receptor in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Jan 5. pii: S1064-7481(17)30001.
    PubMed     Text format    


  13. SULTZER DL, Melrose RJ, Riskin-Jones H, Narvaez TA, et al
    Cholinergic Receptor Binding in Alzheimer Disease and Healthy Aging: Assessment In Vivo with Positron Emission Tomography Imaging.
    Am J Geriatr Psychiatry. 2017 Jan 4. pii: S1064-7481(16)30305.
    PubMed     Text format     Abstract available


  14. GATCHEL JR, Donovan NJ, Locascio JJ, Becker JA, et al
    Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Jan 4. pii: S1064-7481(16)30348.
    PubMed     Text format     Abstract available


    November 2016
  15. KERNER NA, Roose SP, Pelton GH, Ciarleglio A, et al
    Association of Obstructive Sleep Apnea with Episodic Memory and Cerebral Microvascular Pathology: A Preliminary Study.
    Am J Geriatr Psychiatry. 2016 Nov 17. pii: S1064-7481(16)30303.
    PubMed     Text format     Abstract available


  16. REGAN B, Wells Y, Farrow M, O'Halloran P, et al
    MAXCOG-Maximizing Cognition: A Randomized Controlled Trial of the Efficacy of Goal-Oriented Cognitive Rehabilitation for People with Mild Cognitive Impairment and Early Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Nov 16. pii: S1064-7481(16)30302.
    PubMed     Text format     Abstract available


    October 2016
  17. LIN A, Brook J, Grill JD, Teng E, et al
    Participant-Informant Relationships Affect Quality of Life Ratings in Incipient and Clinical Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Oct 13. pii: S1064-7481(16)30273.
    PubMed     Text format     Abstract available


    September 2016
  18. STEFFENS EB, Steffens DC
    Getting on Message: Preventing Alzheimer Disease Through Diet and Exercise.
    Am J Geriatr Psychiatry. 2016;24:738-9.
    PubMed     Text format    


    August 2016
  19. ANTONSDOTTIR IM, Makino KM, Porsteinsson AP
    Dazed and Confused: Medical Cannabis in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Aug 31. pii: S1064-7481(16)30222.
    PubMed     Text format    


  20. PALMER BW
    Sensitive and Specific Preclinical Identification of Alzheimer Disease: A Key to Novel Intervention Development.
    Am J Geriatr Psychiatry. 2016 Aug 4. pii: S1064-7481(16)30178.
    PubMed     Text format    


  21. COHEN AD, Aizenstein HJ
    Brain Amyloidosis and Triglycerides: Preventing Alzheimer Disease Pathology by Treating Vascular Disease?
    Am J Geriatr Psychiatry. 2016;24:613-4.
    PubMed     Text format    


    July 2016
  22. MENDES-SILVA AP, Pereira KS, Tolentino-Araujo GT, Nicolau ES, et al
    Shared Biologic Pathways Between Alzheimer Disease and Major Depression: A Systematic Review of MicroRNA Expression Studies.
    Am J Geriatr Psychiatry. 2016 Jul 25. pii: S1064-7481(16)30185.
    PubMed     Text format     Abstract available


  23. ROY S, Ficarro S, Duberstein P, Chapman BP, et al
    Executive Function and Personality Predict Instrumental Activities of Daily Living in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Jul 4. pii: S1064-7481(16)30165.
    PubMed     Text format     Abstract available


    May 2016
  24. POMARA N, Bruno D
    Major Depression May Lead to Elevations in Potentially Neurotoxic Amyloid Beta Species Independently of Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 May 6. pii: S1064-7481(16)30108.
    PubMed     Text format    


    April 2016
  25. BABULAL GM, Ghoshal N, Head D, Vernon EK, et al
    Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels.
    Am J Geriatr Psychiatry. 2016 Apr 19. pii: S1064-7481(16)30082.
    PubMed     Text format     Abstract available


  26. MAUST DT, Bonar EE, Ilgen MA, Blow FC, et al
    Agitation in Alzheimer Disease as a Qualifying Condition for Medical Marijuana in the United States.
    Am J Geriatr Psychiatry. 2016 Apr 11. pii: S1064-7481(16)30061.
    PubMed     Text format     Abstract available


  27. LOEWENSTEIN DA, Curiel RE, Greig MT, Bauer RM, et al
    A Novel Cognitive Stress Test for the Detection of Preclinical Alzheimer Disease: Discriminative Properties and Relation to Amyloid Load.
    Am J Geriatr Psychiatry. 2016 Apr 4. pii: S1064-7481(16)30004.
    PubMed     Text format     Abstract available


    March 2016
  28. PARK JH, Myung W, Choi J, Kim S, et al
    Extrapyramidal Signs and Cognitive Subdomains in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Mar 15. pii: S1064-7481(16)00217.
    PubMed     Text format     Abstract available


    February 2016
  29. BRUCE ML
    Advances in Methodology in Geriatric Mental Health: Application to Studies of Alzheimer Disease and Related Disorders.
    Am J Geriatr Psychiatry. 2016 Feb 2. pii: S1064-7481(16)00152.
    PubMed     Text format     Abstract available


  30. CHOI HJ, Seo EH, Yi D, Sohn BK, et al
    Amyloid-Independent Amnestic Mild Cognitive Impairment and Serum Apolipoprotein A1 Levels.
    Am J Geriatr Psychiatry. 2016;24:144-53.
    PubMed     Text format     Abstract available


    November 2015
  31. SMALL GW, Greenfield S
    Current and Future Treatments for Alzheimer Disease.
    Am J Geriatr Psychiatry. 2015;23:1101-5.
    PubMed     Text format    


    July 2015
  32. STROHLE A, Schmidt DK, Schultz F, Fricke N, et al
    Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-analysis of Effects on Cognition in Randomized Controlled Trials.
    Am J Geriatr Psychiatry. 2015 Jul 21. pii: S1064-7481(15)00213.
    PubMed     Text format     Abstract available


  33. HONGISTO K, Vaatainen S, Martikainen J, Hallikainen I, et al
    Self-Rated and Caregiver-Rated Quality of Life in Alzheimer Disease with a Focus on Evolving Patient Ability to Respond to Questionnaires: 5-Year Prospective ALSOVA Cohort Study.
    Am J Geriatr Psychiatry. 2015 Jul 17. pii: S1064-7481(15)00206.
    PubMed     Text format     Abstract available


    June 2015
  34. MAK E, Li S, Williams GB, Watson R, et al
    Differential Atrophy of Hippocampal Subfields: A Comparative Study of Dementia with Lewy Bodies and Alzheimer Disease.
    Am J Geriatr Psychiatry. 2015 Jun 25. pii: S1064-7481(15)00192.
    PubMed     Text format     Abstract available


  35. WILLIAMS MA, McKay GJ, Carson R, Craig D, et al
    Age-Related Macular Degeneration-Associated Genes in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2015 Jun 24. pii: S1064-7481(15)00191.
    PubMed     Text format     Abstract available


    May 2015
  36. WROOLIE TE, Kenna HA, Williams KE, Rasgon NL, et al
    Cognitive Effects of Hormone Therapy Continuation or Discontinuation in a Sample of Women at Risk for Alzheimer Disease.
    Am J Geriatr Psychiatry. 2015 May 21. pii: S1064-7481(15)00169.
    PubMed     Text format     Abstract available


  37. WEINTRAUB D, Drye LT, Porsteinsson AP, Rosenberg PB, et al
    Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2015 May 19. pii: S1064-7481(15)00164.
    PubMed     Text format     Abstract available


  38. CINES S, Farrell M, Steffener J, Sullo L, et al
    Examining the Pathways between Self-Awareness and Well-Being in Mild to Moderate Alzheimer Disease.
    Am J Geriatr Psychiatry. 2015 May 19. pii: S1064-7481(15)00163.
    PubMed     Text format     Abstract available


    March 2015
  39. SACUIU S, Insel PS, Mueller S, Tosun D, et al
    Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia.
    Am J Geriatr Psychiatry. 2015 Mar 30. pii: S1064-7481(15)00136.
    PubMed     Text format     Abstract available


    January 2015
  40. WATSON R, Colloby SJ, Blamire AM, O'Brien JT, et al
    Assessment of regional gray matter loss in dementia with Lewy bodies: a surface-based MRI analysis.
    Am J Geriatr Psychiatry. 2015;23:38-46.
    PubMed     Text format     Abstract available


    October 2014
  41. YI D, Lee DY, Sohn BK, Choe YM, et al
    Beta-amyloid associated differential effects of APOE epsilon4 on brain metabolism in cognitively normal elderly.
    Am J Geriatr Psychiatry. 2014;22:961-70.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: